<!DOCTYPE html><html><head><title> Pacifica Code Section 31A-22-S650 </title><link rel="stylesheet" href="../../../assets/style.css"/></head><body>
<b><i>
                      Effective 1/1/2020</i></b>
<br>
<b>31A-22-650.&nbsp;
          </b><b>Health care preauthorization requirements.</b>
<br>
<a id="31A-22-650(1)" name="31A-22-650(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
As used in this section:
<a id="31A-22-650(1)(a)" name="31A-22-650(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
"Adverse preauthorization determination" means a determination by an insurer that health care does not meet the preauthorization requirement for the health care.</td>
</tr>
</tbody></table>
<a id="31A-22-650(1)(b)" name="31A-22-650(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
"Authorization" means a determination by an insurer that for health care with a preauthorization requirement:<a id="31A-22-650(1)(b)(i)" name="31A-22-650(1)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the proposed drug, device, or covered service meets all requirements, restrictions, limitations, and clinical criteria for authorization established by the insurer;</td>
</tr>
</tbody></table>
<a id="31A-22-650(1)(b)(ii)" name="31A-22-650(1)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the drug, device, or covered service is covered by the enrollee's insurance policy; and</td>
</tr>
</tbody></table>
<a id="31A-22-650(1)(b)(iii)" name="31A-22-650(1)(b)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
the insurer will provide coverage for the drug, device, or covered service subject to the provisions of the insurance policy, including any cost sharing responsibilities of the enrollee.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(1)(c)" name="31A-22-650(1)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
"Device" means a prescription device as defined in Section <a href="../../Title58/Chapter17B/58-17b-S102.html?v=C58-17b-S102_2021050520210505">58-17b-102</a>.</td>
</tr>
</tbody></table>
<a id="31A-22-650(1)(d)" name="31A-22-650(1)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
"Drug" means the same as that term is defined in Section <a href="../../Title58/Chapter17B/58-17b-S102.html?v=C58-17b-S102_2021050520210505">58-17b-102</a>.</td>
</tr>
</tbody></table>
<a id="31A-22-650(1)(e)" name="31A-22-650(1)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
"Insurer" means the same as that term is defined in Section <a href="../../Title31A/Chapter22/31A-22-S634.html?v=C31A-22-S634_1800010118000101">31A-22-634</a>.</td>
</tr>
</tbody></table>
<a id="31A-22-650(1)(f)" name="31A-22-650(1)(f)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(f)</td><td style="width:99%">
"Preauthorization requirement" means a requirement by an insurer that an enrollee obtain authorization for a drug, device, or service covered by the insurance policy, before receiving the drug, device, or service.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)" name="31A-22-650(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%"><a id="31A-22-650(2)(a)" name="31A-22-650(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
An insurer may not modify an existing requirement for authorization unless, at least 30 days before the day on which the modification takes effect, the insurer:<a id="31A-22-650(2)(a)(i)" name="31A-22-650(2)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
posts a notice of the modification on the website described in Subsection <a href="../../Title31A/Chapter22/31A-22-S613.5.html?v=C31A-22-S613.5_2019051420200101#31A-22-613.5(6)(a)">31A-22-613.5(6)(a)</a>; and</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(a)(ii)" name="31A-22-650(2)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
if requested by a network provider or the network provider's representative, provides to the network provider by mail or email a written notice of modification to a particular requirement for authorization described in the request from the network provider.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(b)" name="31A-22-650(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
Subsection <a href="#31A-22-650(2)(a)">(2)(a)</a> does not apply if:<a id="31A-22-650(2)(b)(i)" name="31A-22-650(2)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
complying with Subsection <a href="#31A-22-650(2)(a)">(2)(a)</a> would create a danger to the enrollee's health or safety; or</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(b)(ii)" name="31A-22-650(2)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the modification is for a newly covered drug or device.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(c)" name="31A-22-650(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
An insurer may not revoke an authorization for a drug, device, or covered service if:<a id="31A-22-650(2)(c)(i)" name="31A-22-650(2)(c)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the network provider submits a request for authorization for the drug, device, or covered service to the insurer;</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(c)(ii)" name="31A-22-650(2)(c)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the insurer grants the authorization requested under Subsection <a href="#31A-22-650(2)(c)(i)">(2)(c)(i)</a>;</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(c)(iii)" name="31A-22-650(2)(c)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
the network provider renders the drug, device, or covered service to the enrollee in accordance with the authorization and any terms and conditions of the network provider's contract with the insurer;</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(c)(iv)" name="31A-22-650(2)(c)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
on the day on which the network provider renders the drug, device, or covered service to the enrollee:
<a id="31A-22-650(2)(c)(iv)(A)" name="31A-22-650(2)(c)(iv)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
the enrollee is eligible for coverage under the enrollee's insurance policy; and</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(c)(iv)(B)" name="31A-22-650(2)(c)(iv)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
the enrollee's condition or circumstances related to the enrollee's care have not changed;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(c)(v)" name="31A-22-650(2)(c)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
the network provider submits an accurate claim that matches the information in the request for authorization under Subsection <a href="#31A-22-650(2)(c)(i)">(2)(c)(i)</a>; and</td>
</tr>
</tbody></table>
<a id="31A-22-650(2)(c)(vi)" name="31A-22-650(2)(c)(vi)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(vi)</td><td style="width:99%">
the authorization was not based on fraudulent or materially incorrect information from the network provider.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)" name="31A-22-650(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%"><a id="31A-22-650(3)(a)" name="31A-22-650(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
An insurer that receives a request for authorization shall treat the request as a pre-service claim as defined in 29 C.F.R. Sec. 2560.503-1 and process the request in accordance with:<a id="31A-22-650(3)(a)(i)" name="31A-22-650(3)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
29 C.F.R. Sec. 2560.503-1, regardless of whether the coverage is offered through an individual or group health insurance policy;</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(a)(ii)" name="31A-22-650(3)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
Subsection <a href="../../Title31A/Chapter4/31A-4-S116.html?v=C31A-4-S116_2019051420200101#31A-4-116(2)">31A-4-116(2)</a>; and</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(a)(iii)" name="31A-22-650(3)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
Section <a href="../../Title31A/Chapter22/31A-22-S629.html?v=C31A-22-S629_2018050820180508">31A-22-629</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(b)" name="31A-22-650(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
If a network provider submits a claim to an insurer that includes an unintentional error that results in a denial of the claim, the insurer shall permit the network provider with an opportunity to resubmit the claim with corrected information within a reasonable amount of time.</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(c)" name="31A-22-650(3)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
Except as provided in Subsection <a href="#31A-22-650(3)(d)">(3)(d)</a>, the appeal of an adverse preauthorization determination regarding clinical or medical necessity as requested by a physician may only be reviewed by a physician who is currently licensed as a physician and surgeon in a state, district, or territory of the United States.</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(d)" name="31A-22-650(3)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
The appeal of an adverse determination requested by a physician regarding clinical or medical necessity of a drug, may only be reviewed by an individual who is currently licensed in a state, district, or territory of the United States as:<a id="31A-22-650(3)(d)(i)" name="31A-22-650(3)(d)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
a physician and surgeon; or</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(d)(ii)" name="31A-22-650(3)(d)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
a pharmacist.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(e)" name="31A-22-650(3)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
An insurer shall ensure that an adverse preauthorization determination regarding clinical or medical necessity is made by an individual who:<a id="31A-22-650(3)(e)(i)" name="31A-22-650(3)(e)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
has knowledge of the medical condition or disease of the enrollee for whom the authorization is requested; or</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(e)(ii)" name="31A-22-650(3)(e)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
consults with a specialist who has knowledge of the medical condition or disease of the enrollee for whom the authorization is requested regarding the request before making the determination.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(3)(f)" name="31A-22-650(3)(f)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(f)</td><td style="width:99%">
An insurer shall specify how long an authorization is valid.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(4)" name="31A-22-650(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%"><a id="31A-22-650(4)(a)" name="31A-22-650(4)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
An insurer that removes a drug from the insurer's formulary shall:<a id="31A-22-650(4)(a)(i)" name="31A-22-650(4)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
permit an enrollee, an enrollee's designee, or an enrollee's network provider to request an exemption from the change to the formulary for the purpose of providing the patient with continuity of care; and</td>
</tr>
</tbody></table>
<a id="31A-22-650(4)(a)(ii)" name="31A-22-650(4)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
have a process to review and make a decision regarding an exemption requested under Subsection <a href="#31A-22-650(4)(a)(i)">(4)(a)(i)</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(4)(b)" name="31A-22-650(4)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
If an insurer makes a change to the formulary for a drug in the middle of a plan year, the insurer may not implement the changes for an enrollee that is on an active course of treatment for the drug unless the insurer provides the enrollee with notice at least 30 days before the day on which the change is implemented.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="31A-22-650(5)" name="31A-22-650(5)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(5)</td><td style="width:99%">
Before April 1, 2021, and before April 1 of each year thereafter, an insurer with a preauthorization requirement shall report to the department, for the previous calendar year, the percentage of authorizations, not including a claim involving urgent care as defined in 29 C.F.R. Sec. 2560.503-1, for which the insurer notified a provider regarding an authorization or adverse preauthorization determination more than one week after the day on which the insurer received the request for authorization.</td>
</tr>
</tbody></table>
<a id="31A-22-650(6)" name="31A-22-650(6)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(6)</td><td style="width:99%">
An insurer may not have a preauthorization requirement for emergency health care as described in Section <a href="../../Title31A/Chapter22/31A-22-S627.html?v=C31A-22-S627_2022050420220504">31A-22-627</a>.</td>
</tr>
</tbody></table>
<br>
<br>Enacted by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=439&amp;sess=2019GS">439</a>, 2019 General Session<br>
</body></html>